SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-29
👔
Scribe Therapeutics, Inc.
@SCTX_InsiderForm 4 Filing: GORDON CARL L Buys $15.0M of $SCTX
INSIDER PURCHASE
⚡ MATERIALITY: 8/10
corporate issuer
Scribe Therapeutics, Inc.
Ticker: $SCTX
Transaction Value
$15.0M
Price/Share: $11.12
transaction date
2026-07-27
Shares: 1,348,825
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GORDON CARL L, holds the title of Director at Scribe Therapeutics, Inc..
On 2026-07-27, the insider transacted 1,348,825 shares.The shares were transacted at a weighted average price of $11.12 per share, resulting in a total market-relevant value of $15.0M.
Executive Summary Summary
GORDON CARL L (Director) bought $15.0M of $SCTX
Post-Transaction Position: 1,348,825 shares
SEC Accession No: 0000947871-26-000734 (CIK: 1282930)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.